Cardiovascular Systems Inc

Delisted

CIK 1180145fmd_1PGW3R8E0KN584KD246CC14D7BManufacturing · Surgical & Medical Instruments & ApparatusTemplate: Standard

Coverage: Jul 01, 2009 to Dec 31, 2022, 52 periods

Income Statement · Annual · Millions · USD
Line item	FY2013	FY2014	FY2015	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022
Total revenues	–	–	–	–	205	217	248	237	259	236
Cost of revenue	24	31	40	35	39	39	48	49	61	63
Gross profit	80	106	142	143	165	178	200	188	198	173
Research and development	15	21	31	26	23	27	33	43	41	37
Selling, general and administrative	87	118	144	163	144	149	168	170	167	171
Total operating expenses	102	139	175	199	167	175	201	215	210	209
Operating income	(22)	(33)	(33)	(56)	(2)	2	(1)	(27)	(12)	(36)
Interest expense	1	1	0	0	1	2	2	2	2	2
Interest and investment income	–	–	–	–	0	1	2	2	0	1
Other non-operating income (expense)	(2)	(2)	(0)	0	(0)	(0)	1	(0)	(1)	(1)
Income before taxes	–	–	(33)	(56)	(2)	2	(0)	(27)	(13)	(37)
Income tax expense	–	–	0	0	0	0	0	0	0	0
Net income from continuing operations	–	–	(33)	(56)	(2)	2	(0)	(27)	(13)	(37)
Net income	(24)	(35)	(33)	(56)	(2)	2	(0)	(27)	(13)	(37)
Net income to common shareholders	–	–	–	–	–	–	–	(27)	(13)	(37)